Ascribe Bioscience Inc. STTR Phase I Award, July 2022
A STTR Phase I contract was awarded to Acribe Biosciences in July, 2022 for $299,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Is a
Award Amount (USD)
299,999
0
Government Branch
Date Awarded
July 25, 2022
0
End Date
June 30, 2023
0
SBIR/STTR Award Recipient
Contract Number (US Government)
1R41AI170268-01A1
0
Award Phase
Phase I
0
Award Type
STTR
0
Official Website
Find more entities like Ascribe Bioscience Inc. STTR Phase I Award, July 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
